SNA · Snap-on Inc
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-08-13 | Pagliari Aldo John |
Sr VP - Finance & CFO |
Convert↑
Filing footnotes — Common Stock (Direct)
The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025. Includes 17.4326 shares acquired under a dividend reinvestment plan. |
Common Stock
|
8,000 |
| 2026-08-13 | Pagliari Aldo John |
Sr VP - Finance & CFO |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025. Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025. Option fully vested. |
Stock Option (Right to Buy)
|
8,000 |
| 2026-08-13 | Pagliari Aldo John |
Sr VP - Finance & CFO |
Sell↓
Filing footnotes — Common Stock (Direct)
The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025. This transaction was executed in multiple trades at prices ranging from $406.56 to $407.29. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
Common Stock
|
208 |
| 2026-08-13 | Pagliari Aldo John |
Sr VP - Finance & CFO |
Sell↓
Filing footnotes — Common Stock (Direct)
The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025. This transaction was executed in multiple trades at prices ranging from $404.45 to $405.41 The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
Common Stock
|
441 |
| 2026-08-13 | Pagliari Aldo John |
Sr VP - Finance & CFO |
Sell↓
Filing footnotes — Common Stock (Direct)
The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025. |
Common Stock
|
40 |
| 2026-08-13 | Pagliari Aldo John |
Sr VP - Finance & CFO |
Sell↓
Filing footnotes — Common Stock (Direct)
The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025. This transaction was executed in multiple trades at prices ranging from $403.45 to $404.42. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
Common Stock
|
2,564 |
| 2026-08-13 | Pagliari Aldo John |
Sr VP - Finance & CFO |
Sell↓
Filing footnotes — Common Stock (Direct)
The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025. This transaction was executed in multiple trades at prices ranging from $402.43 to $403.41. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
Common Stock
|
1,447 |
| 2026-08-13 | Pagliari Aldo John |
Sr VP - Finance & CFO |
Sell↓
Filing footnotes — Common Stock (Direct)
The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025. This transaction was executed in multiple trades at prices ranging from $405.50 to $406.47. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
Common Stock
|
831 |
| 2026-08-11 | Lemerand June C |
VP & Chief Information Officer |
Convert↑
|
Common Stock
|
1,200 |
| 2026-08-11 | Lemerand June C |
VP & Chief Information Officer |
Convert↑
Filing footnotes — Common Stock (Direct)
Includes 7.9901 shares acquired under the Snap-on Incorporated Employee Stock Ownership Plan and 12.4462 shares acquired under a dividend reinvestment plan. |
Common Stock
|
1,200 |
| 2026-08-11 | Lemerand June C |
VP & Chief Information Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $413.49 to $414.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
Common Stock
|
1,952 |
| 2026-08-11 | Lemerand June C |
VP & Chief Information Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $412.80 to $413.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
Common Stock
|
2,275 |
| 2026-08-11 | Lemerand June C |
VP & Chief Information Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $413.855 to $414.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
Common Stock
|
125 |
| 2026-08-11 | Lemerand June C |
VP & Chief Information Officer |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Exercise of Rule 16b-3 stock option. Option fully vested. |
Stock Option (Right to Buy)
|
1,200 |
| 2026-08-11 | Lemerand June C |
VP & Chief Information Officer |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
Exercise of Rule 16b-3 stock option. Option fully vested. |
Stock Option (Right to Buy)
|
1,200 |
| 2026-08-06 | Boyd Iain |
VP - Operations Development |
Convert↑
Filing footnotes — Common Stock (Direct)
The option was exercised and the underlying shares were sold pursuant to a Rule 10b5-1 Plan, which was adopted on February 24, 2026. Includes 76.6213 shares acquired under the Snap-on Incorporated Employee Stock Ownership Plan and 4.6701 shares acquired under a dividend reinvestment plan. |
Common Stock
|
1,558 |
| 2026-08-06 | Boyd Iain |
VP - Operations Development |
Sell↓
Filing footnotes — Common Stock (Direct)
The option was exercised and the underlying shares were sold pursuant to a Rule 10b5-1 Plan, which was adopted on February 24, 2026. |
Common Stock
|
1,878 |
| 2026-08-06 | Boyd Iain |
VP - Operations Development |
Convert↑
Filing footnotes — Common Stock (Direct)
The option was exercised and the underlying shares were sold pursuant to a Rule 10b5-1 Plan, which was adopted on February 24, 2026. |
Common Stock
|
160 |
| 2026-08-06 | Boyd Iain |
VP - Operations Development |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was exercised and the underlying shares were sold pursuant to a Rule 10b5-1 Plan, which was adopted on February 24, 2026. Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on February 24, 2026. Option fully vested. |
Stock Option (Right to Buy)
|
160 |
| 2026-08-06 | Boyd Iain |
VP - Operations Development |
Convert↑
Filing footnotes — Common Stock (Direct)
The option was exercised and the underlying shares were sold pursuant to a Rule 10b5-1 Plan, which was adopted on February 24, 2026. |
Common Stock
|
160 |
| 2026-08-06 | Boyd Iain |
VP - Operations Development |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was exercised and the underlying shares were sold pursuant to a Rule 10b5-1 Plan, which was adopted on February 24, 2026. Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on February 24, 2026. Option fully vested. |
Stock Option (Right to Buy)
|
1,558 |
| 2026-08-06 | Boyd Iain |
VP - Operations Development |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was exercised and the underlying shares were sold pursuant to a Rule 10b5-1 Plan, which was adopted on February 24, 2026. Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on February 24, 2026. Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column. |
Stock Option (Right to Buy)
|
160 |
| 2026-07-31 | HOLDEN JAMES P |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Payment of fees in stock under the Company's Directors' 1993 Fee Plan. Includes 20.5696 shares acquired under a dividend reinvestment plan. |
Common Stock
|
33 |
| 2026-07-28 | Chambers Timothy L |
Sr VP & Pres - Tools |
Sell↓
Filing footnotes — Common Stock (Direct)
The option was exercised and the underlying shares were sold pursuant to a Rule 10b5-1 Plan, which was adopted on February 27, 2026. |
Common Stock
|
20 |
| 2026-07-28 | Chambers Timothy L |
Sr VP & Pres - Tools |
Sell↓
Filing footnotes — Common Stock (Direct)
The option was exercised and the underlying shares were sold pursuant to a Rule 10b5-1 Plan, which was adopted on February 27, 2026. This transaction was executed in multiple trades at prices ranging from $419.00 to $419.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
Common Stock
|
9,091 |
| 2026-07-28 | Chambers Timothy L |
Sr VP & Pres - Tools |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was exercised and the underlying shares were sold pursuant to a Rule 10b5-1 Plan, which was adopted on February 27, 2026. Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on February 27, 2026. Option fully vested. |
Stock Option (Right to Buy)
|
9,111 |
| 2026-07-28 | Chambers Timothy L |
Sr VP & Pres - Tools |
Convert↑
Filing footnotes — Common Stock (Direct)
The option was exercised and the underlying shares were sold pursuant to a Rule 10b5-1 Plan, which was adopted on February 27, 2026. |
Common Stock
|
9,111 |
| 2026-07-17 | Chambers Timothy L |
Sr VP & Pres - Tools |
Convert↑
Filing footnotes — Common Stock (Direct)
The option was exercised and the underlying shares were sold pursuant to a Rule 10b5-1 Plan, which was adopted on February 27, 2026. Includes 16.8567 shares acquired under the Snap-on Incorporated Employee Stock Ownership Plan and 6.7254 shares acquired under a dividend reinvestment plan. |
Common Stock
|
389 |
| 2026-07-17 | Chambers Timothy L |
Sr VP & Pres - Tools |
Sell↓
Filing footnotes — Common Stock (Direct)
The option was exercised and the underlying shares were sold pursuant to a Rule 10b5-1 Plan, which was adopted on February 27, 2026. This transaction was executed in multiple trades at prices ranging from $419.00 to $419.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
Common Stock
|
389 |
| 2026-07-17 | Chambers Timothy L |
Sr VP & Pres - Tools |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was exercised and the underlying shares were sold pursuant to a Rule 10b5-1 Plan, which was adopted on February 27, 2026. Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on February 27, 2026. Option fully vested. |
Stock Option (Right to Buy)
|
389 |
| 2026-07-01 | Miller Richard Thomas |
VP, Gen Counsel & Secretary |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was exercised and the underlying shares were sold pursuant to a Rule 10b5-1 Plan, which was adopted on March 11, 2026. Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on March 11, 2026. Option fully vested. |
Stock Option (Right to Buy)
|
2,000 |
| 2026-07-01 | Miller Richard Thomas |
VP, Gen Counsel & Secretary |
Convert↑
Filing footnotes — Common Stock (Direct)
The option was exercised and the underlying shares were sold pursuant to a Rule 10b5-1 Plan, which was adopted on March 11, 2026. Includes 2.2912 shares acquired under a dividend reinvestment plan. |
Common Stock
|
2,000 |
| 2026-07-01 | Miller Richard Thomas |
VP, Gen Counsel & Secretary |
Sell↓
Filing footnotes — Common Stock (Direct)
The option was exercised and the underlying shares were sold pursuant to a Rule 10b5-1 Plan, which was adopted on March 11, 2026. |
Common Stock
|
2,000 |
| 2026-06-10 | Miller Richard Thomas |
VP, Gen Counsel & Secretary |
Sell↓
Filing footnotes — Common Stock (Direct)
The shares were sold pursuant to a Rule 10b5-1 Plan, which was adopted on March 11, 2026. Includes 2.3172 shares acquired under a dividend reinvestment plan. |
Common Stock
|
427 |
| 2026-06-10 | Arregui Jesus |
Sr VP & President - Commercial |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $383.29 to $384.27. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
Common Stock
|
2,676 |
| 2026-06-10 | Arregui Jesus |
Sr VP & President - Commercial |
Other↓
|
Common Stock
|
3,249 |
| 2026-06-10 | Arregui Jesus |
Sr VP & President - Commercial |
Convert↓
Filing footnotes — Stock Appreciation Rights (Direct)
Exercise of Rule 16b-3 stock appreciation rights. Stock appreciation rights grant fully vested. |
Stock Appreciation Rights
|
7,500 |
| 2026-06-10 | Arregui Jesus |
Sr VP & President - Commercial |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $384.31 to $384.76. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
Common Stock
|
602 |
| 2026-06-10 | Arregui Jesus |
Sr VP & President - Commercial |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $385.61 to $386.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
Common Stock
|
400 |
| 2026-06-10 | Arregui Jesus |
Sr VP & President - Commercial |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $382.255 to $383.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
Common Stock
|
573 |
| 2026-06-10 | Arregui Jesus |
Sr VP & President - Commercial |
Convert↑
Filing footnotes — Common Stock (Direct)
Includes 33.7134 shares acquired under the Snap-on Incorporated Employee Stock Ownership Plan and 0.0087 shares acquired under a dividend reinvestment plan. |
Common Stock
|
7,500 |
| 2026-06-04 | Pagliari Aldo John |
Sr VP - Finance & CFO |
Sell↓
Filing footnotes — Common Stock (Direct)
This transaction was executed in multiple trades at prices ranging from $379.005 to $379.75. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
Common Stock
|
1,330 |
| 2026-05-14 | Pagliari Aldo John |
Sr VP - Finance & CFO |
Convert↑
Filing footnotes — Common Stock (Direct)
The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025. Includes 17.6301 shares acquired under a dividend reinvestment plan. |
Common Stock
|
8,000 |
| 2026-05-14 | Pagliari Aldo John |
Sr VP - Finance & CFO |
Sell↓
Filing footnotes — Common Stock (Direct)
The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025. This transaction was executed in multiple trades at prices ranging from $367.57 to $368.51. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
Common Stock
|
1,674 |
| 2026-05-14 | Pagliari Aldo John |
Sr VP - Finance & CFO |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025. Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025. Option fully vested. |
Stock Option (Right to Buy)
|
8,000 |
| 2026-05-14 | Pagliari Aldo John |
Sr VP - Finance & CFO |
Sell↓
Filing footnotes — Common Stock (Direct)
The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025. This transaction was executed in multiple trades at prices ranging from $366.57 to $367.55. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
Common Stock
|
3,029 |
| 2026-05-14 | Pagliari Aldo John |
Sr VP - Finance & CFO |
Sell↓
Filing footnotes — Common Stock (Direct)
The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025. This transaction was executed in multiple trades at prices ranging from $365.56 to $366.54. The price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
Common Stock
|
1,010 |
| 2026-05-05 | PINCHUK NICHOLAS T |
Director, Chairman, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025. This transaction was executed in multiple trades at prices ranging from $373.24 to $374.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
Common Stock
|
704 |
| 2026-05-05 | PINCHUK NICHOLAS T |
Director, Chairman, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025. |
Common Stock
|
389 |
| 2026-05-05 | PINCHUK NICHOLAS T |
Director, Chairman, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on November 3, 2025. This transaction was executed in multiple trades at prices ranging from $377.26 to $378.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated. |
Common Stock
|
2,480 |